CVS 4th-quarter profit rises on higher prescription volume
Feb 11 (Reuters) - CVS Caremark Corp on Tuesday posted higher quarterly profit as it processed more prescriptions and benefited from the introduction of new generic drugs.
CVS, which operates the No. 2 U.S. drugstore chain and a major pharmacy benefits management business, earned $1.27 billion from continuing operations, or $1.05 per share, in the fourth quarter, up from $1.13 billion, or 90 cents per share, a year earlier.
Revenue rose 4.6 percent to $32.83 billion. Sales of general merchandise at stores open at least a year fell 1.9 percent as fewer shoppers came in to CVS' drugstores.
- U.S. nurse defies Maine's Ebola quarantine, takes bike ride |
- Clashes erupt as Israeli police kill Palestinian suspected of shooting Jewish far-rightist
- SoftBank's humanoid robot lands job as Nescafe salesman
- Ukraine gas supplies in doubt as Russia seeks EU payment deal
- Dollar surges as Fed ends QE on hawkish note